Tirzepatide ( Zepbound ): A combination GLP-1 agonist and GIP agonist, which acts similarly to liraglutide and semaglutide
It targets both GLP-1 and GIP (gastric inhibitory polypeptide) receptors to trigger enhanced metabolic effects
Wang J, Zhao D, Ding CZ, Guo F, Wu LN, Huang FJ, et al
Highlights The first incretin hormone, gastric inhibitory peptide, was identified in the early 1970s, followed by the discovery of glucagonlike peptide 1 (GLP-1) in the 1980s [1]
Avokadoggsalladsrostat brd | Portioner: 2 Avokadoggsalladsrostat brd | Portioner: 2 Ingredienser: 4 stora vita gg 1 stor avokado 2 matskedar majonns eller naturell yoghurt 2 tsk frsk citronsaft 1 selleristjlk, finhackad (ca 3 matskedar) 1 matsked finhackad grslk, persilja eller dill Salt och nymalen svartpeppar, efter smak Steg: Rr i selleri och grslk och krydda sedan med salt och peppar efter smak
The drug has a long half-life, which means it can be administered monthly or less frequently, giving the drug the potential to improve adherence and long-term weight control, according to Jay Bradner, executive vice president of research and development at Amgen
